
Stem Cell Therapies are well researched and hold
promise in many areas of medicine.
​
Stem Cells & Arthritis
Trial results suggest that cord blood stem cells may have important therapeutic value for patients with psoriatic arthritis, particularly for those who cannot tolerate standard treatments.
​
-
The potential role of adult stem cells in the management of the rheumatic diseases
-
Umbilical cord blood stem cell treatment for a patient with psoriatic arthritis
-
Intra-Articular Injection of Mesenchymal Stem Cells for the Treatment of Osteoarthritis of the Knee
-
Treatment of Knee Osteoarthritis With Allogeneic Bone Marrow Mesenchymal Stem Cells
Stem Cells & Autoimmune Disorders
The incidence and prevalence of inflammatory bowel disease is increasing in Western countries. Current therapies, ranging from anti- inflammatory drugs, immunosuppressive regimens to new biological therapies, remain inadequate.
​​
-
Haemopoietic stem and progenitor cells in the treatment of severe autoimmune diseases
-
Improvement of Inflammatory Bowel Disease After Allogeneic Stem-Cell Transplantation
-
Stem Cells as Potential Targeted Therapy for Inflammatory Bowel Disease
Stem Cells & Orthopedics
Chronic low back pain is one of the major causes of disability and thus has a major socioeconomic impact. Intervertebral disc degeneration is the main cause of chronic low back pain. Treatment for chronic discogenic low back pain has traditionally been limited to either conservative management or surgical fusion. Recent clinical outcomes indicate that human umbilical cord tissue-derived mesenchymal stem cell transplantation is a favorable alternative method for the treatment of chronic discogenic low back pain.
​
-
Human Umbilical Cord Blood–Derived Mesenchymal Stem Cells in the Cultured Rabbit Intervertebral Disc
-
Cellular Supplementation Technologies for Painful Spine Disorders
-
Regenerative Treatments to Enhance Orthopedic Surgical Outcome
-
Bone Fracture Healing with Umbilico-Placental Mononuclear Cells
-
Stem Cell Therapies for Treatment of Cartilage and Bone Disorders
-
Adult Human MSC Delivered…Knee Following Partial Medial Meniscectomy
​
​
Stem Cells & Diabetes
While the regenerative potential of stem cells can be harnessed to make available a self-replenishing supply of glucose-responsive insulin-producing cells, their immunomodulatory properties may potentially be used to prevent, arrest, or reverse autoimmunity, ameliorate innate/alloimmune graft rejection, and prevent recurrence of Type 1 diabetes.
​
Stem Cells & Kidney Function
Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease worldwide. Excess accumulation of extracellular matrix and the epithelial-to-mesenchymal transition contribute to renal fibrosis, which is associated with DKD. Delayed treatment with human umbilical cord blood–derived stem cells may show a therapeutic effect on DKD progression.
​
-
Hematopoietic stem cells ameliorate cisplatin-induced acute renal failure
-
Predictive and preventive potentials of stem cells in diabetic nephropathy
Stem Cells & Neurology
Human umbilical cord blood cells (HUCBCs), a prolific source of non-embryonic or adult stem cells, have emerged as effective and relatively safe immunomodulators and neuroprotectors, reducing behavioral impairment in animal models of Alzheimer’s disease (AD), Parkinson’s disease, amyotrophic lateral sclerosis, traumatic brain injury, spinal cord injury, and stroke.
​
-
Biodistribution of Infused Human Umbilical Cord Blood Cells in Alzheimer’s Disease-Like Murine Model
-
Human Umbilical Cord Blood Stem Cells Infusion in Spinal Cord Injury
-
Traumatic Brain Injury and Stem Cell: Pathophysiology and Update on Recent Treatment Modalities​
​
​
Stem Cells & Osteoarthritis
Intra-articular injection of mesenchymal stem cells into the osteoarthritic knee improved function and pain of the knee joint without causing adverse events. Radiological, arthroscopic, and histological measures consistently demonstrated decreased of articular cartilage defects by regeneration of hyaline-like articular cartilage. These results are promising to encourage large randomized clinical trials, and there is optimism about this new step for the treatment of osteoarthritis of the knee.
​
-
Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee
-
Treatment of knee osteoarthritis with allogeneic bone marrow mesenchymal stem cells
-
MSC therapy for knee osteoarthritis, 5 years follow-up of 3 patients
Stem Cells & Skin Trauma/Disease
Burn injuries represent one of the major worldwide public health problems causing more severe physiological stress than other traumas. Effective treatment of burn injuries is mandatory to prevent the numerous life-threatening complications and possible disabilities. Stem cells, a population of multipotent cells retaining the properties of self-renewal and differentiation, are the main player in tissue regeneration after major trauma.
​
Stem Cells & Stroke
Intravenously administered HUCBC enter brain, survive, migrate, and improve functional recovery after stroke. HUCBC transplantation may provide a cell source to treat stroke.
​
-
Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke
-
Timing of Cord Blood Treatment After Experimental Stroke Determines Therapeutic Efficacy
Stem Cells & Wharton's Jelly
Wharton’s jelly is a gelatinous substance that provides insulation and protection within the umbilical cord. Stem cells are present in Wharton’s jelly, as well as in umbilical cord blood.
Both Wharton’s jelly and cord blood stem cells contain mesenchymal stem cells (MSC), while cord blood stem cells also contain hematopoietic stem cells as well as other non-hematopoietic stem cells. When compared to cord blood, Wharton’s jelly may have a more homogenous population of MSCs. Because Wharton’s jelly appears to have less cell variability, it is considered homogenous; while cord blood appears to have more variability and is therefore considered heterogeneous.
​
​
Stem Cells & Cancer
Cellular immunotherapy involving the adoptive transfer of immune cells that potently recognize and eliminate malignantly transformed cells has become a promising new tool in the anticancer armory. Studies suggest that the unique biological properties of umbilical cord blood (UCB) cells could precipitate enhanced anticancer activity; hence, UCB could be an optimal source for immunotherapy with the potential to provide products with “off-the-shelf” availability.
​
-
Anticancer cellular immunotherapies derived from umbilical cord blood
-
Cord blood T cells mediate enhanced antitumor effects compared with adult peripheral blood T cells
-
Ex vivo expansion protocol for human tumor specific T cells for adoptive T cell therapy
-
Umbilical cord blood-derived cellular products for cancer immunotherapy
Stem Cells & Cardiovascular Disease
Cardiovascular disease constitutes a major cause of morbidity and mortality worldwide, and it is important to develop new therapeutic strategies to reduce its immense social and economic impact. Stem cell therapy has shown promising results in several pre-clinical studies and clinical trials that have reported the safety and efficacy of cell transplantation for a wide range of therapeutic applications.
​
-
Placental mesenchymal and cord blood stem cell therapy for dilated cardiomyopathy
-
Successful Stem Cell Therapy Using Umbilical Cord Blood-Derived Multipotent Stem Cells
Stem Cells & Dentistry
New technologies that facilitate solid alveolar ridge augmentation are receiving considerable attention in the field of prosthodontics because of the growing requirement for esthetic and functional reconstruction by dental implant treatments. Recently, several studies have demonstrated potential advantages for stem-cell-based therapies in regenerative treatments.
​
